I picked this up on Twitter: Can't find any other news....as any one heard something from Sanofi?
"Adam Feuerstein @adamfeuerstein 16 Nov $SNY Jak inhibitor fedratinib placed on FDA clinical hold due to toxicity. $INCY competitor."
Andy Biotech @AndyBiotech 16 Nov @adamfeuerstein Interesting, maybe this explains $INCY's 30%+ rally in the past wk. Link?
ps. SNY Q3 ER: fedratinib dev halted as mono in PV